New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies
Authors:
- 24 November 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 246, 114959
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Effect of Ambient Temperature on the Clinical Manifestations of Experimental Diffuse Cutaneous Leishmaniasis in a Rodent ModelVector-Borne and Zoonotic Diseases, 2012
- 3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitorsJournal of Molecular Modeling, 2011
- Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline TafenoquineAntimicrobial Agents and Chemotherapy, 2010
- New antileishmanial candidates and lead compoundsCurrent Opinion in Chemical Biology, 2010
- Synthesis, Cytotoxicity and Antileishmanial Activity of SomeN‐(2‐(indol‐3‐yl)ethyl)‐7‐chloroquinolin‐4‐aminesChemical Biology & Drug Design, 2010
- Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural DatabaseJournal of Chemical Information and Modeling, 2010
- Neglected tropical diseasesBritish Medical Bulletin, 2009
- In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasisJournal of Pharmacy and Pharmacology, 2006
- Structures of Leishmania major Pteridine Reductase Complexes Reveal the Active Site Features Important for Ligand Binding and to Guide Inhibitor DesignJournal of Molecular Biology, 2005
- A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania speciesParasitology Research, 2002